Interestingly, the phosphorylated EGFR was predominantly in the nuclei (Figure 1), which was in strong agreement as other studies, suggested that the nuclear EGFR positively associated with poor survival outcomes in patients with breast cancer (Lo et al, 2005). Here, EGFR is linked to breast cancer.